Instrument Inactif

Gouvernance IGI LABORIGI NYSE

Actions

Cours en clôture NYSE Autres places de cotation
- ^USD	-

26/07/22	Teligent, Inc. a fait faillite	CI
25/05/22	Deuxième motion pour la prolongation de la période d'exclusivité approuvée pour Teligent, Inc.	CI

Comité Exécutif: IGI LABORIGI

Dirigeant

Fonctions occupéesDepuis

Joseph Benesch

59 ans

Comptroller/Controller/Auditor

01/06/2021

Composition du Conseil d'Administration: IGI LABORIGI

Administrateur

ComitésDepuis

Carole Ben-Maimon

67 ans

Audit Committee	29/03/2016
Governance Committee	29/03/2016
Nominating Committee	29/03/2016

Thomas Sabatino

67 ans

Audit Committee	01/09/2017
Compensation Committee Chair	15/07/2020
Organization Committee Chair	01/09/2017

Bradley Scher

65 ans

Director/Board Member

14/10/2021

Anciens Dirigeants et Administrateurs: IGI LABORIGI

Insider

Fonctions occupées

DepuisJusqu'au

Alyssa Lozynski

Director of Finance/CFO

23/09/2021

01/06/2022

Mark Mantel

Corporate Officer/Principal	-	01/04/2022
Sales & Marketing	01/04/2019	-

John E. Celentano

Director/Board Member	23/03/2015	15/07/2020
Chairman	15/07/2020	01/01/2022
Independent Dir/Board Member	23/03/2015	01/01/2022

Philip K. Yachmetz

General Counsel	16/07/2020	08/10/2021
Corporate Secretary	16/07/2020	08/10/2021

Timothy B. Sawyer

Director/Board Member	04/02/2020	08/10/2021
Chief Executive Officer	04/02/2020	08/10/2021
President	04/02/2020	08/10/2021

R. Pate

Director/Board Member	23/02/2021	24/09/2021
Independent Dir/Board Member	23/02/2021	24/09/2021

William Marth

Director/Board Member	15/02/2021	23/09/2021
Independent Dir/Board Member	15/02/2021	23/09/2021

Ernest de Paolantonio

Director of Finance/CFO

15/04/2021

23/09/2021

Steven Hubrig Koehler

Director/Board Member	01/10/2014	21/07/2021
Independent Dir/Board Member	01/10/2014	21/07/2021

Bhaskar Chaudhuri

Director/Board Member	01/11/2010	21/07/2021
Independent Dir/Board Member	01/11/2010	21/07/2021

Steven Pinsky

Director of Finance/CFO

15/04/2021

James Gale

Director/Board Member	15/05/2009	01/01/2014
Chairman	01/01/2014	15/07/2020
Independent Dir/Board Member	15/05/2009	15/07/2020

Jason Grenfell-Gardner

Director/Board Member	02/08/2012	04/02/2020
Chief Executive Officer	30/07/2012	04/02/2020
President	30/07/2012	04/02/2020

Martin Wilson

General Counsel

25/04/2017

30/12/2019

Steve Richardson

Chief Tech/Sci/R&D Officer

05/10/2015

16/08/2019

Antonio di Nicola

Chief Operating Officer

01/05/2019

Shannon Johnston

Human Resources Officer

01/01/2016

01/03/2019

Jenniffer L. Collins

Director of Finance/CFO	09/08/2011	05/02/2018
Investor Relations Contact	21/07/2011	05/02/2018
Corporate Secretary	21/07/2011	05/02/2018

Narendra N. Borkar

Director/Board Member	21/09/2009	18/05/2017
Independent Dir/Board Member	15/09/2009	18/05/2017

Fred Weiss

Compliance Officer

01/10/2015

01/03/2017

Eric Muse

Corporate Officer/Principal

01/06/2016

Damian Finio

Director/Board Member	02/04/2014	11/08/2014
Director of Finance/CFO	05/02/2018	14/10/2020
Investor Relations Contact	05/02/2018	14/10/2020
Corporate Secretary	-	-

Joyce Erony

Comptroller/Controller/Auditor	21/07/2011	22/07/2011
Director/Board Member	07/04/2009	02/06/2009
Chairman	02/06/2009	29/05/2014
Independent Dir/Board Member	13/03/2009	29/05/2014
Corporate Secretary	13/03/2009	25/05/2012

Michael B. Hemric

Director/Board Member	03/07/2009	01/04/2014
Independent Dir/Board Member	01/07/2009	01/04/2014

Thomas Vandervort

Corporate Officer/Principal

01/01/2014

Nadya Lawrence

Chief Tech/Sci/R&D Officer

01/09/2013

Kenneth J. Miller

Chief Tech/Sci/R&D Officer

19/12/2012

01/08/2013

Sanjay Samudre

Chief Operating Officer

01/07/2013

Charles E. Moore

Director/Board Member	01/06/2011	30/07/2012
Corporate Officer/Principal	22/02/2010	01/04/2010
President	01/04/2010	30/07/2012

Jane E. Hager

Director/Board Member	01/01/1982	27/07/2010
Founder	27/07/2010	22/05/2012
Independent Dir/Board Member	01/01/1982	22/05/2012

Phillip S. Forte

Comptroller/Controller/Auditor	05/06/2009	11/01/2011
Director of Finance/CFO	22/02/2010	11/01/2011
Corporate Secretary	27/07/2010	11/01/2011

Devendra Shah

Chief Tech/Sci/R&D Officer

01/06/2010

Hemanshu N Pandya

President

30/06/2009

01/04/2010

Terrence O'Donnell

Director/Board Member

01/01/1993

15/09/2009

Stephen J. Morris

Director/Board Member

01/01/1999

01/07/2009

Carlene Ann Lloyd

Director of Finance/CFO	01/01/1998	03/10/2008
Corporate Secretary	01/01/1998	03/10/2008

Alessandra Daigneault

General Counsel

01/10/2000

01/05/2008

Frank Gerardi

Chairman

01/06/2003

Sunil K. Pai

Director/Board Member

01/06/2006

Denisse Goldbarg

Sales & Marketing

01/01/2000

01/01/2004

Rajiv Mathur

Corporate Officer/Principal	01/01/1992	01/01/2001
President	12/09/2005	29/06/2009

Alexander J. Mandl

Chief Executive Officer	01/01/1996	01/01/2001
Chairman	01/01/1996	01/01/2001

Sunday Daniels

Sales & Marketing

Bruce Epley

Chief Operating Officer

Robert Schwartz

Corporate Officer/Principal

George Galgano

Chief Operating Officer

27/07/2010

Donna Cordasco

Corporate Officer/Principal

27/07/2010

Richard Coash

Corporate Officer/Principal

27/07/2010

Kevin J. Bratton

Director of Finance/CFO	-	-
Treasurer	-	-

Justine Kostka

Director of Finance/CFO

Domenic N. Golato

Director of Finance/CFO

Earl Lewis

Director/Board Member

Donald W. Joseph

Director/Board Member

Constantine L. Hampers

Director/Board Member

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	6
Femme	0

Dont comité exécutif

Homme	1
Femme	0

Dont Administrateurs

Homme	3
Femme	0

Teligent, Inc. est une société pharmaceutique générique. La société se concentre sur le développement, la fabrication et la commercialisation d'un portefeuille de produits pharmaceutiques génériques sous sa propre marque et sous une marque privée pour d'autres sociétés pharmaceutiques, sous forme topique, injectable, complexe et autres formes de dosage. Elle fournit également des services de développement et de fabrication sous contrat aux marchés des produits pharmaceutiques et cosmétiques sur ordonnance et en vente libre. Sous sa propre marque, la société commercialise et vend des produits pharmaceutiques topiques génériques et des produits pharmaceutiques injectables génériques et de marque aux États-Unis. Aux États-Unis, la société commercialise environ 37 produits pharmaceutiques topiques génériques et un produit pharmaceutique injectable de marque. Le portefeuille de produits injectables stériles à usage hospitalier de la société comprend des céphalosporines, Cefotan (Cefotetan pour injection), Fortaz (Ceftazidime) et Zinacef (Cefuroxime Sodium).

Employés

Secteur

Plus d'informations sur la société